HIV drug comparison study seeks clues to shrink hidden virus
NCT ID NCT05584397
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 40 people with HIV to see if a common drug, tenofovir, causes more immune system activation and helps the virus hide better in the body. Participants are already on stable HIV treatment and will provide blood and gut samples. The goal is to find ways to reduce the hidden HIV reservoir and improve long-term health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Washington Positive Research and the Gastroenterology Clinic at Harborview Medical Center
Seattle, Washington, 98104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Peer support may lift the cloud of loneliness for older gay men with HIV
- Can peer mentors help gay men with HIV stay in care?
- Could a stress hormone be behind the hidden danger of low blood sugar?
- HIV and hidden health risks: a major study probes the link
- Grape powder may help aging immune systems — a trial puts it to the test